Organization typesPublic Company

Products 31 to 40 of 122

Cellic CTec by Novozymes
Biotech components: Enzyme
Business models: B2B
Country of production: Denmark
Country of distribution: USA + Italy
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 29,300,000 USD
Funding types: Shareholder Investment + Government
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: NZYM-B (CPH)
Value chain stage: Input
Clearwood (TM) Patchouli Oil by Amyris + Firmenich
Biotech components: Plant
Business models: B2C
Country of production: USA + Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/02/15 12:43 (3 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product
Cottonase Pectate Lyase by DuPont + Genencor
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: Netherlands + USA + Argentina + China + India + Pakistan + Singapore
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
CRISPR-Cas9 by CRISPR
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Research
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/11/08 13:59 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: CRSP (NASDAQ)
Value chain stage: Finished Product
crPhage by Locus Biosciences
Biotech components: Gene Editing + Molecule + Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (2 years ago)
Date last modified: 2019/09/12 15:10 (2 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Health + Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Danisco Xylanase by DuPont
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 2,147,483,647 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Feed
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Canada + Switzerland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/05/15 15:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Open Release
Source: Web search
Trading symbol: BAS (ETR)
Value chain stage: Input
Detalzym GA L-E5 Glucoamylase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: Germany + USA + China + Japan
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/12/26 15:16 (3 years ago)
Known funding amount: 2,147,483,647 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: No longer on the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input
digitalDNA by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/01/30 12:02 (3 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Platform
Dragon Silk by Kraig Biocraft Laboratories
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA + Vietnam
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 5,000,000 USD
Funding types: Government + Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: Scientist Magazine
Trading symbol: KBLB (OTCMKTS)
Value chain stage: Input